WO2001057248A2 - Polynucleotide arrays and their use in sequencing - Google Patents

Polynucleotide arrays and their use in sequencing Download PDF

Info

Publication number
WO2001057248A2
WO2001057248A2 PCT/GB2001/000407 GB0100407W WO0157248A2 WO 2001057248 A2 WO2001057248 A2 WO 2001057248A2 GB 0100407 W GB0100407 W GB 0100407W WO 0157248 A2 WO0157248 A2 WO 0157248A2
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotide
array
molecules
molecule
target
Prior art date
Application number
PCT/GB2001/000407
Other languages
French (fr)
Other versions
WO2001057248A3 (en
Inventor
Shankar Balasubramanian
David Bentley
Original Assignee
Solexa Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solexa Ltd. filed Critical Solexa Ltd.
Priority to CA002398168A priority Critical patent/CA2398168A1/en
Priority to IL15083601A priority patent/IL150836A0/en
Priority to JP2001555871A priority patent/JP2003521693A/en
Priority to AU30384/01A priority patent/AU3038401A/en
Priority to EP01902529A priority patent/EP1252332A2/en
Publication of WO2001057248A2 publication Critical patent/WO2001057248A2/en
Publication of WO2001057248A3 publication Critical patent/WO2001057248A3/en
Priority to IS6489A priority patent/IS6489A/en
Priority to HK02109277.3A priority patent/HK1047771A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00527—Sheets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/0054—Means for coding or tagging the apparatus or the reagents
    • B01J2219/00572—Chemical means
    • B01J2219/00576—Chemical means fluorophore
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00675—In-situ synthesis on the substrate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B01J2219/00702—Processes involving means for analysing and characterising the products
    • B01J2219/00707—Processes involving means for analysing and characterising the products separated from the reactor apparatus
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00722—Nucleotides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00729—Peptide nucleic acids [PNA]

Definitions

  • This invention relates to devices having an array of polynucleotides, and to the sequencing of polynucleotides. in particular, this invention discloses methods for determining the sequence of arrayed polynucleotides.
  • nucleic acids An example of the technologies that have improved the study of nucleic acids, is the development of fabricated arrays of immobilised nucleic acids. These arrays typically consist of a high-density matrix of polynucleotides immobilised onto a solid support material. Fodor et al, Trends in Biotechnology (1994) 12:19-26, describes ways of assembling the nucleic acids using a chemically sensitized glass surface protected by a mask, but exposed at defined areas to allow attachment of suitably modified nucleotide phosphoramidites. Fabricated arrays may also be manufactured by the technique of "spotting" known polynucleotides onto a solid support at predetermined positions (e.g. Stimpson et a/ PNAS (1995) 92:6379-6383).
  • array technology A further development in array technology is the attachment of the polynucleotides to the solid support material to form single molecule arrays.
  • Arrays of this type are disclosed in WO-A-00/06770. The advantage of these arrays is that reactions can be monitored at the single molecule level and information on large numbers of single molecules can be collated from a single reaction.
  • US-A- 5302509 discloses a method to sequence polynucleotides immobilised on a solid support. The method relies on the incorporation of fluorescently-labeled, 3'-blocked bases A, G, C and T to the immobilised polynucleotide, in the presence of DNA polymerase.
  • the polymerase incorporates a base complementary to the target polynucleotide, but is prevented from further addition by the 3'-blocking group.
  • the label of the incorporated base can then be determined and the blocking group removed by chemical cleavage to allow further polymerisation to occur.
  • Sequencing polynucleotides on a solid support can be difficult as the polynucleotide is typically bound to the solid support via a hybridisation reaction with a support-bound complement. Occasionally the conditions used in the sequencing protocol result in disruption to the bonds formed on hybridisation and the target polynucleotide is removed from the array.
  • Canard et al., Gene (1994) 148:1-6 discloses a DNA sequencing procedure using a relatively harsh alkali denaturation step to remove fluorescent labels from nucleotides incorporated onto a template.
  • the alkali treatment results in melting of the primer-template duplex, and Canard suggests providing a hairpin-like primer to the template to overcome this problem.
  • the hairpin-like primer is suggested only in the context of the harsh alkali treatment with a homogeneous sample of template DNA.
  • WO-A-98/20019 discloses compositions and methods for the preparation of nucleic acid arrays.
  • the general disclosure relates to the preparation of high density multi-molecule arrays, achieved by immobilising polynucleotides on microscopic beads attached to a solid support. Many different uses are proposed for the arrays.
  • WO-A-97/08183 relates to nucleic acid capture molecules. Hairpin loop structures are disclosed, but only in the context of capture molecules for use in hybridisation-based nucleic acid detection methods.
  • WO-A-97/04131 discloses primer amplification experiments carried out with polynucleotide hairpin structures. The general teaching is of methods for amplification of the hairpin structures, and it is clear that the structures contain a polynucleotide sequence to which a separate primer sequence is hybridised. The primer associates with the hairpin only through the hybridisation reaction. Summary of the Invention
  • the present invention is based on the realisation that sample preparation and sequence analysis procedures can be improved if the target polynucleotide is maintained in spatial relationship to the primer, and the target and primer are linked via a bond stronger than that of hybridisation.
  • a device comprises an array of polynucleotide molecules immobilised on a solid support, wherein each molecule comprises a polynucleotide duplex linked via a covalent bond to form a hairpin loop structure, one end of which comprises a target polynucleotide, and the array has a surface density which allows the target polynucleotides to be individually resolved.
  • the device of the invention is used in a procedure to determine the sequence of the target polynucleotide.
  • a method for the preparation of the device comprises ligating a target polynucleotide to the 5'-end of a first molecule capable of forming a duplex as defined above, and immobilising the first molecule to the solid sur ace either before or after ligation.
  • the present invention provides a method for capturing target polynucleotides from solution and immobilising them on an array to form a stable primer-template complex.
  • the target polynucleotide is maintained on the array together with the primer by bonds stronger than those formed in hybridisation, and so conditions which would otherwise result in the target or primer being dissociated from the array, may be used. This may be of particular use in genotyping experiments, where an array of genomic DNA is prepared, to allow multiple sequencing reactions to be performed. Description of the Invention
  • the present invention is the formation of arrays of polynucleotides, the polynucleotides comprising a hairpin loop structure, one end of which comprises a target polynucleotide, the other end comprising a relatively short polynucleotide capable of acting as a primer in the polymerase reaction.
  • the arrays are typically high density arrays, and there are preferably at least 10 3 molecules/cm 2 , more preferably at least 10 5 molecules/cm 2 and most preferably 10 6 -10 9 molecules/cm 2 .
  • the molecules immobilised on the solid support surface are also preferably at a density so that they can be considered to be single molecules, i.e. each can be individually resolved.
  • the term "individually resolved” is used herein to specify that, when visualised, it is possible to distinguish one molecule on the array from its neighbouring molecules. Separation between individual molecules on the array will be determined, in part, by the particular technique used to resolve the individual molecules. It will usually be the target polynucleotide portion that is individually resolved, as it is this which will be interrogated, e.g. by the incorporation of detectable bases.
  • a confocal scanning microscope may be used to scan the surface of the array with a laser, to image directly a fluorophore incorporated on the individual arrayed molecule by fluorescence.
  • a sensitive 2-D detector such as a change-coupled detector, can be used to provide a 2-D image representing the individual molecules on the array. Resolving single molecules on the array with a 2-D detector is possible if adjacent molecules are separated by a distance of approximately at least 250nm, preferably at least 300nm and more preferably by at least 350nm.
  • the arrayed polynucleotide molecules each comprise a polynucleotide duplex which is used to retain a primer and a target polynucleotide in spatial relationship to each other. This ensures that the primer is able to perform its priming function during a polymerase-based sequencing procedure, and is not removed during any washing step in the procedure.
  • the target polynucleotide is capable of being interrogated.
  • the term "capable of interrogation" refers to the ability of the target to act as a template during the polymerase reaction. The target polynucleotide is therefore interrogated by the incorporation of bases and the polymerase enzyme.
  • the duplex forms a hairpin loop structure, and the primer and target polynucleotides are comprised at the respective ends of the hairpin loop structure.
  • hairpin loop structure refers to a molecular stem and loop formed from the hybridisation of complementary polynucleotides that are covalently linked at one end.
  • the stem comprises the hybridised polynucleotides and the loop is the region that links the two complementary polynucleotides. Anything from a 10 to 20 (or more) base pair double-stranded (duplex) region may be used to form the stem.
  • the structure may be formed from a single-stranded polynucleotide having complementary regions.
  • the loop in this embodiment may be anything from 2 or more non- hybridised nucleotides.
  • the structure is formed from two separate polynucleotides with complementary regions, the two polynucleotides being linked (and the loop being formed) by a linker moiety.
  • the linker moiety forms a covalent attachment between the ends of the two polynucleotides.
  • Linker moieties suitable for use in this embodiment will be apparent to the skilled person.
  • the linker moiety may be polyethylene glycol (PEG).
  • 'polynucleotide' is intended to refer to nucleic acids in general, including DNA, RNA and synthetic analogs, e.g. PNA. DNA is preferred.
  • Preparation of the devices to form the target polynucleotide on the array may be carried out by methods known to those skilled in the art.
  • the target polynucleotide will usually be one to which a sequence determination is to be made.
  • a preferred method is to form a first molecule capable of forming a hairpin structure, and ligate the target polynucleotide to this. Ligation may be carried out either prior to or after immobilisation to the solid support.
  • the resulting structure comprises the single- stranded target polynucleotide at one end of the hairpin and a primer polynucleotide at the other end.
  • the target polynucleotide is genomic DNA purified using conventional methods.
  • the genomic DNA may be PCR-amplified or used directly to generate fragments of DNA using either restriction endonucleases, other suitable enzymes, a mechanical form of fragmentation or a non-enzymatic chemical fragmentation method.
  • restriction endonucleases hairpin structures bearing a complementary restriction site at the end of the first hairpin may be used, and selective ligation of one strand of the DNA sample fragments may be achieved by one of two methods.
  • Method 1 uses a first hairpin whose restriction site contains a phosphorylated 5' end. Using this method, it may be necessary to first de- phosphorylate the restriction-cleaved genomic or other DNA fragments prior to ligation such that only one sample strand is covalently ligated to the hairpin.
  • Method 2 in the design of the hairpin, a single (or more) base gap can be incorporated at the 3' end (the receded strand) such that upon ligation of the
  • DNA fragments only one strand is covalently joined to the hairpin.
  • the base gap can be formed by hybridising a further separate polynucleotide to the 5'-end of the first hairpin structure. On ligation, the DNA fragment has one strand joined to the 5'-end of the first hairpin, and the other strand joined to the 3'-end of the further polynucleotide. The further polynucleotide (and the other strand of the fragment) may then be removed by disrupting hybridisation.
  • the net result should be covalent ligation of only one strand of a DNA fragment of genomic or other DNA, to the hairpin.
  • ligation reactions may be carried out in solution at optimised concentrations based on conventional ligation chemistry, for example, carried out by DNA ligases or non- enzymatic chemical ligation.
  • the ends can be filled in with Klenow fragment to generate blunt-ended fragments which may be blunt- end-ligated onto blunt-ended hairpins.
  • the blunt-ended DNA fragments may be ligated to oligonucleotide adapters which are designed to allow compatible ligation with the sticky-end hairpins, in the manner described previously.
  • the hairpin-ligated DNA constructs may then be covalently attached to the surface of a solid support to generate a single molecule array (SMA), or ligation may follow attachment to form the array.
  • SMA single molecule array
  • the arrays may then be used in procedures to determine the sequence of the target polynucleotide.
  • the recognition sequence of the restriction or other nuclease enzyme will provide 4, 6, 8 bases or more of known sequence (dependent on the enzyme).
  • Further sequencing of between 10 and 20 bases on the SMA should provide sufficient overall sequence information to place that stretch of DNA into unique context with a total human genome sequence, thus enabling the sequence information to be used for genotyping and more specifically single nucleotide polymorphism (SNP) scoring.
  • Simple calculations have suggested the following based on sequencing a 10 7 molecule SMA prepared from hairpin ligation: For an 8 base pair recognition sequence, a single restriction enzyme will generate approximately 10 6 ends of DNA.
  • the sequencing method that is used to characterise the bound target may be any known in the art that measures the sequential incorporation of bases onto an extending strand.
  • a suitable technique is disclosed in US-A-5302509 requiring the monitoring of sequential incorporation of fluorescently-labeled bases onto a complement using the polymerase reaction.
  • Suitable reagents, including fluorescently-labeled nucleotides will be apparent to the skilled person.
  • Immobilisation of the polynucleotides to the solid support may be carried out by any method known in the art, provided that covalent attachment is achieved.
  • the solid support may be any of the conventional supports used in
  • DNA chips e.g. glass slides, ceramic, silicon or plastics materials.
  • the support will typically be a flat planar surface, usually of approximately 1cm 2 .
  • the single molecule array can be prepared by contacting a suitably prepared solid support with a dilute solution containing the polynucleotides to be arrayed. Techniques for preparing the arrays are detailed in WO-A-00/06770. Example This Example illustrates the preparation of single molecule arrays by direct covalent attachment of hairpin loop structures to glass.
  • the DNA structure was designed as a self-priming template system with an internal amino group attached as an amino deoxy-thymidine held by two 18 atom hexaethylene glycol (heg) spacers, and was synthesised by conventional DNA synthesis techniques using phosphoramidite monomers.
  • one slide was inverted so that the chamber coverslip contacted the objective lens of an inverted microscope (Nikon TE200) via an immersion oil interface.
  • a 60° fused silica dispersion prism was coupled optically to the back of the slide through a thin film of glycerol.
  • Laser light was directed at the prism such that at the glass/sample interface it subtends an angle of approximately 68° to th normal ot the slide and subsequently undergoes Total Internal Reflection (TIR).
  • TIR Total Internal Reflection
  • ICCD Intensified Charge Coupled Device
  • Single molecules were identified by single points of fluorescence with average intensities greater than 3x that of the background. Fluorescence from a single molecule was confined to a few pixels, typically a 3x3 matrix at 100x magnification, and had a narrow Gaussian-like intensity profile. Single molecule fluorescence was also characterised by a one-step photobleaching process in the time course of the intensity and was used to distinguish single molecules from pixel regions containing two or more molecules, which exhibit multi-step processes. To count molecules, a threshold for fluorescence intensities was first set to exclude background noise. For a control sample the background was essentially the thermal noise of the ICCD measured to be 76 counts with a standard deviation of only 6 counts.
  • a threshold was arbitrarily chosen as a linear combination of the background, the average counts over an image and the standard deviation over an image. In general, the latter two quantities provide a measure of the number of pixels and range of intensities above background. This method gave rise to threshold levels which were at least 12 standard deviations above the background with a probability of less than 1 in 144 pixels contributing from noise.
  • a single molecule fluorescent point By defining a single molecule fluorescent point as being at least a 2x2 matrix of pixels and no larger than a 7x7, the probability of a single background pixel contributing to the counting was eliminated and clusters were ignored. In this manner, the surface density of single molecules of DNA-Cy3 was measured at approximately 500 per 100 ⁇ m x 100 ⁇ m image or 5 x 10 6 cm 2 .

Abstract

A device for use in polynucleotide sequencing procedures comprises an array of polynucleotide molecules capable of interrogation and immobilised on a solid surface, wherein the array has a density which allows the molecules to be individually resolved. The molecules on the array comprise a target polynucleotide and a primer sequence, the primer being maintained in spatial relationship to the target, both being linked via a covalent bond. The device may be used in genotyping experiments, in which an array of genomic DNA is prepared to allow multiple sequencing reactions to be performed.

Description

POLYNUCLEOTIDE ARRAYS AND THEIR USE IN SEQUENCING Field of the Invention
This invention relates to devices having an array of polynucleotides, and to the sequencing of polynucleotides. in particular, this invention discloses methods for determining the sequence of arrayed polynucleotides. Background to the Invention
Advances in the study of molecules have been led, in part, by improvement in technologies used to characterise the molecules or their biological reactions. In particular, the study of the nucleic acids DNA and RNA has benefitted from developing technologies used for sequence analysis and the study of hybridisation events.
An example of the technologies that have improved the study of nucleic acids, is the development of fabricated arrays of immobilised nucleic acids. These arrays typically consist of a high-density matrix of polynucleotides immobilised onto a solid support material. Fodor et al, Trends in Biotechnology (1994) 12:19-26, describes ways of assembling the nucleic acids using a chemically sensitized glass surface protected by a mask, but exposed at defined areas to allow attachment of suitably modified nucleotide phosphoramidites. Fabricated arrays may also be manufactured by the technique of "spotting" known polynucleotides onto a solid support at predetermined positions (e.g. Stimpson et a/ PNAS (1995) 92:6379-6383).
A further development in array technology is the attachment of the polynucleotides to the solid support material to form single molecule arrays. Arrays of this type are disclosed in WO-A-00/06770. The advantage of these arrays is that reactions can be monitored at the single molecule level and information on large numbers of single molecules can be collated from a single reaction.
Although these arrays offer particular advantages in sequencing experiments, the preparation of arrays at the single molecule level may be more difficult than at the multi-molecule level, where losses of target polynucleotide can be tolerated due to the multiplicity of the array. There is therefore a need for improvements in the preparation of the single molecule arrays for sequencing procedures.
Furthermore, for DNA arrays to be useful their sequences must be determined. US-A- 5302509 discloses a method to sequence polynucleotides immobilised on a solid support. The method relies on the incorporation of fluorescently-labeled, 3'-blocked bases A, G, C and T to the immobilised polynucleotide, in the presence of DNA polymerase. The polymerase incorporates a base complementary to the target polynucleotide, but is prevented from further addition by the 3'-blocking group. The label of the incorporated base can then be determined and the blocking group removed by chemical cleavage to allow further polymerisation to occur.
Sequencing polynucleotides on a solid support can be difficult as the polynucleotide is typically bound to the solid support via a hybridisation reaction with a support-bound complement. Occasionally the conditions used in the sequencing protocol result in disruption to the bonds formed on hybridisation and the target polynucleotide is removed from the array.
Canard et al., Gene (1994) 148:1-6, discloses a DNA sequencing procedure using a relatively harsh alkali denaturation step to remove fluorescent labels from nucleotides incorporated onto a template. The alkali treatment results in melting of the primer-template duplex, and Canard suggests providing a hairpin-like primer to the template to overcome this problem. The hairpin-like primer is suggested only in the context of the harsh alkali treatment with a homogeneous sample of template DNA.
WO-A-98/20019 discloses compositions and methods for the preparation of nucleic acid arrays. The general disclosure relates to the preparation of high density multi-molecule arrays, achieved by immobilising polynucleotides on microscopic beads attached to a solid support. Many different uses are proposed for the arrays.
WO-A-97/08183 relates to nucleic acid capture molecules. Hairpin loop structures are disclosed, but only in the context of capture molecules for use in hybridisation-based nucleic acid detection methods. WO-A-97/04131 discloses primer amplification experiments carried out with polynucleotide hairpin structures. The general teaching is of methods for amplification of the hairpin structures, and it is clear that the structures contain a polynucleotide sequence to which a separate primer sequence is hybridised. The primer associates with the hairpin only through the hybridisation reaction. Summary of the Invention
The present invention is based on the realisation that sample preparation and sequence analysis procedures can be improved if the target polynucleotide is maintained in spatial relationship to the primer, and the target and primer are linked via a bond stronger than that of hybridisation.
According to a first aspect of the invention, a device comprises an array of polynucleotide molecules immobilised on a solid support, wherein each molecule comprises a polynucleotide duplex linked via a covalent bond to form a hairpin loop structure, one end of which comprises a target polynucleotide, and the array has a surface density which allows the target polynucleotides to be individually resolved.
According to a further aspect of the invention, the device of the invention is used in a procedure to determine the sequence of the target polynucleotide.
According to a third aspect, a method for the preparation of the device comprises ligating a target polynucleotide to the 5'-end of a first molecule capable of forming a duplex as defined above, and immobilising the first molecule to the solid sur ace either before or after ligation.
The present invention provides a method for capturing target polynucleotides from solution and immobilising them on an array to form a stable primer-template complex. The target polynucleotide is maintained on the array together with the primer by bonds stronger than those formed in hybridisation, and so conditions which would otherwise result in the target or primer being dissociated from the array, may be used. This may be of particular use in genotyping experiments, where an array of genomic DNA is prepared, to allow multiple sequencing reactions to be performed. Description of the Invention
The present invention is the formation of arrays of polynucleotides, the polynucleotides comprising a hairpin loop structure, one end of which comprises a target polynucleotide, the other end comprising a relatively short polynucleotide capable of acting as a primer in the polymerase reaction.
The arrays are typically high density arrays, and there are preferably at least 103 molecules/cm2, more preferably at least 105 molecules/cm2 and most preferably 106-109 molecules/cm2. The molecules immobilised on the solid support surface are also preferably at a density so that they can be considered to be single molecules, i.e. each can be individually resolved. The term "individually resolved" is used herein to specify that, when visualised, it is possible to distinguish one molecule on the array from its neighbouring molecules. Separation between individual molecules on the array will be determined, in part, by the particular technique used to resolve the individual molecules. It will usually be the target polynucleotide portion that is individually resolved, as it is this which will be interrogated, e.g. by the incorporation of detectable bases.
Apparatus used to image arrays are known to those skilled in the art. For example, a confocal scanning microscope may be used to scan the surface of the array with a laser, to image directly a fluorophore incorporated on the individual arrayed molecule by fluorescence. Alternatively, a sensitive 2-D detector, such as a change-coupled detector, can be used to provide a 2-D image representing the individual molecules on the array. Resolving single molecules on the array with a 2-D detector is possible if adjacent molecules are separated by a distance of approximately at least 250nm, preferably at least 300nm and more preferably by at least 350nm.
The arrayed polynucleotide molecules each comprise a polynucleotide duplex which is used to retain a primer and a target polynucleotide in spatial relationship to each other. This ensures that the primer is able to perform its priming function during a polymerase-based sequencing procedure, and is not removed during any washing step in the procedure. The target polynucleotide is capable of being interrogated. The term "capable of interrogation" refers to the ability of the target to act as a template during the polymerase reaction. The target polynucleotide is therefore interrogated by the incorporation of bases and the polymerase enzyme. The duplex forms a hairpin loop structure, and the primer and target polynucleotides are comprised at the respective ends of the hairpin loop structure. The term "hairpin loop structure" refers to a molecular stem and loop formed from the hybridisation of complementary polynucleotides that are covalently linked at one end. The stem comprises the hybridised polynucleotides and the loop is the region that links the two complementary polynucleotides. Anything from a 10 to 20 (or more) base pair double-stranded (duplex) region may be used to form the stem. In one embodiment, the structure may be formed from a single-stranded polynucleotide having complementary regions. The loop in this embodiment may be anything from 2 or more non- hybridised nucleotides. In a second embodiment, the structure is formed from two separate polynucleotides with complementary regions, the two polynucleotides being linked (and the loop being formed) by a linker moiety. The linker moiety forms a covalent attachment between the ends of the two polynucleotides. Linker moieties suitable for use in this embodiment will be apparent to the skilled person. For example, the linker moiety may be polyethylene glycol (PEG).
The term 'polynucleotide' is intended to refer to nucleic acids in general, including DNA, RNA and synthetic analogs, e.g. PNA. DNA is preferred.
Preparation of the devices to form the target polynucleotide on the array may be carried out by methods known to those skilled in the art. The target polynucleotide will usually be one to which a sequence determination is to be made.
There are many different ways of forming the hairpin structure to incorporate the target polynucleotide. However, a preferred method is to form a first molecule capable of forming a hairpin structure, and ligate the target polynucleotide to this. Ligation may be carried out either prior to or after immobilisation to the solid support. The resulting structure comprises the single- stranded target polynucleotide at one end of the hairpin and a primer polynucleotide at the other end.
In one embodiment, the target polynucleotide is genomic DNA purified using conventional methods. The genomic DNA may be PCR-amplified or used directly to generate fragments of DNA using either restriction endonucleases, other suitable enzymes, a mechanical form of fragmentation or a non-enzymatic chemical fragmentation method. In the case of fragments generated by restriction endonucleases, hairpin structures bearing a complementary restriction site at the end of the first hairpin may be used, and selective ligation of one strand of the DNA sample fragments may be achieved by one of two methods.
Method 1 uses a first hairpin whose restriction site contains a phosphorylated 5' end. Using this method, it may be necessary to first de- phosphorylate the restriction-cleaved genomic or other DNA fragments prior to ligation such that only one sample strand is covalently ligated to the hairpin.
Method 2: in the design of the hairpin, a single (or more) base gap can be incorporated at the 3' end (the receded strand) such that upon ligation of the
DNA fragments only one strand is covalently joined to the hairpin. The base gap can be formed by hybridising a further separate polynucleotide to the 5'-end of the first hairpin structure. On ligation, the DNA fragment has one strand joined to the 5'-end of the first hairpin, and the other strand joined to the 3'-end of the further polynucleotide. The further polynucleotide (and the other strand of the fragment) may then be removed by disrupting hybridisation.
In either case, the net result should be covalent ligation of only one strand of a DNA fragment of genomic or other DNA, to the hairpin. Such ligation reactions may be carried out in solution at optimised concentrations based on conventional ligation chemistry, for example, carried out by DNA ligases or non- enzymatic chemical ligation. Should the fragmented DNA be generated by random shearing of genomic DNA or polymerase, then the ends can be filled in with Klenow fragment to generate blunt-ended fragments which may be blunt- end-ligated onto blunt-ended hairpins. Alternatively, the blunt-ended DNA fragments may be ligated to oligonucleotide adapters which are designed to allow compatible ligation with the sticky-end hairpins, in the manner described previously.
The hairpin-ligated DNA constructs may then be covalently attached to the surface of a solid support to generate a single molecule array (SMA), or ligation may follow attachment to form the array.
The arrays may then be used in procedures to determine the sequence of the target polynucleotide. In the case that the target fragments are generated via restriction digest of genomic DNA, the recognition sequence of the restriction or other nuclease enzyme will provide 4, 6, 8 bases or more of known sequence (dependent on the enzyme). Further sequencing of between 10 and 20 bases on the SMA should provide sufficient overall sequence information to place that stretch of DNA into unique context with a total human genome sequence, thus enabling the sequence information to be used for genotyping and more specifically single nucleotide polymorphism (SNP) scoring. Simple calculations have suggested the following based on sequencing a 107 molecule SMA prepared from hairpin ligation: For an 8 base pair recognition sequence, a single restriction enzyme will generate approximately 106 ends of DNA. If a stretch of 13 bases is sequenced on the SMA (i.e. 13 x 106 bases), approximately 13,000 SNPs will be detected. One application of such a sample preparation and sequencing format would in general be for SNP discovery in pharmaco-genetic analysis. The approach is therefore suitable for forensic analysis or any other system which requires unambiguous identification of individuals to a level as low 103 SNPs.
It is of course possible to sequence the complete target polynucleotide. The sequencing method that is used to characterise the bound target may be any known in the art that measures the sequential incorporation of bases onto an extending strand. A suitable technique is disclosed in US-A-5302509 requiring the monitoring of sequential incorporation of fluorescently-labeled bases onto a complement using the polymerase reaction. Alternatives will be apparent to the skilled person. Suitable reagents, including fluorescently-labeled nucleotides will be apparent to the skilled person. Immobilisation of the polynucleotides to the solid support may be carried out by any method known in the art, provided that covalent attachment is achieved. The solid support may be any of the conventional supports used in
"DNA chips", e.g. glass slides, ceramic, silicon or plastics materials. The support will typically be a flat planar surface, usually of approximately 1cm2.
The single molecule array can be prepared by contacting a suitably prepared solid support with a dilute solution containing the polynucleotides to be arrayed. Techniques for preparing the arrays are detailed in WO-A-00/06770. Example This Example illustrates the preparation of single molecule arrays by direct covalent attachment of hairpin loop structures to glass.
A solution of 1 % glycidoxypropylt methoxy-silane in 95% ethanol/5% water with 2 drops H2SO4 per 500 ml was stirred for 5 minutes at room temperature. Clean, dry Spectrosil-2000 slides (TSL, UK) were placed in the solution and the stirring stopped. After 1 hour the slides were removed, rinsed with ethanol, dried under N2 and oven-cured for 30 min. at 100°C. These 'epoxide' modified slides were then treated with 1 μM of labelled DNA (5'-Cy3- CTGCTGAAGCGTCGGCAGGT-heg-aminodT-heg-ACCTGCCGACGCT-3') (SEQ ID NOS. 1 and 2) in 50 mM potassium phosphate buffer, pH 7.4 for 18 hours at room temperature and, prior to analysis, flushed with 50 mM potassium phosphate, 1 mM EDTA, pH 7.4. The coupling reactions were performed in sealed teflon blocks under a pre-mounted coverslip to prevent evaporation of the sample and allow direct imaging.
The DNA structure was designed as a self-priming template system with an internal amino group attached as an amino deoxy-thymidine held by two 18 atom hexaethylene glycol (heg) spacers, and was synthesised by conventional DNA synthesis techniques using phosphoramidite monomers.
For imaging, one slide was inverted so that the chamber coverslip contacted the objective lens of an inverted microscope (Nikon TE200) via an immersion oil interface. A 60° fused silica dispersion prism was coupled optically to the back of the slide through a thin film of glycerol. Laser light was directed at the prism such that at the glass/sample interface it subtends an angle of approximately 68° to th normal ot the slide and subsequently undergoes Total Internal Reflection (TIR). The critical angle for glass/water interface is 66°. Fluorescence from single molecules of DNA-Cy3, produced by excitation with the surface-specific evanescent wave following TIR, was collected by the objective lens of the microscope and imaged onto an Intensified Charge Coupled Device (ICCD) camera (Pentamax, Princeton Instruments, NJ). The image was recorded using a 532nm excitation (frequency-doubled solid-state Nd:YAG, Antares, Coherent) with a 580nm fluorescence (580DF30, Omega Optics, USA) filter for Cy3. Images were recorded with an exposure time of 500ms at the maximum gain of 10 on the ICCD. Laser powers incident at the prism were 50mW at 532nm.
Single molecules were identified by single points of fluorescence with average intensities greater than 3x that of the background. Fluorescence from a single molecule was confined to a few pixels, typically a 3x3 matrix at 100x magnification, and had a narrow Gaussian-like intensity profile. Single molecule fluorescence was also characterised by a one-step photobleaching process in the time course of the intensity and was used to distinguish single molecules from pixel regions containing two or more molecules, which exhibit multi-step processes. To count molecules, a threshold for fluorescence intensities was first set to exclude background noise. For a control sample the background was essentially the thermal noise of the ICCD measured to be 76 counts with a standard deviation of only 6 counts. A threshold was arbitrarily chosen as a linear combination of the background, the average counts over an image and the standard deviation over an image. In general, the latter two quantities provide a measure of the number of pixels and range of intensities above background. This method gave rise to threshold levels which were at least 12 standard deviations above the background with a probability of less than 1 in 144 pixels contributing from noise. By defining a single molecule fluorescent point as being at least a 2x2 matrix of pixels and no larger than a 7x7, the probability of a single background pixel contributing to the counting was eliminated and clusters were ignored. In this manner, the surface density of single molecules of DNA-Cy3 was measured at approximately 500 per 100 μm x 100 μm image or 5 x 106 cm2.

Claims

1. A device comprising an array of polynucleotide molecules immobilised on a solid surface, wherein each molecule comprises a polynucleotide duplex linked via a covalent bond to form a hairpin loop structure, one end of which comprises a target polynucleotide, and the array has a surface density which allows the target polynucleotides to be individually resolved.
2. A device according to claim 1 , wherein immobilisation to the solid surface is via covalent attachment.
3. A device according to claiml or claim 2, wherein the array has a density of at least 103 molecules/cm2.
4. A device according to any preceding claim, wherein the array has a density of at least 106 molecules/cm2.
5. A device according to any preceding claim, wherein the spacing between adjacent target polynucleotides on the array is at least 100nm.
6. A device according to any preceding claim, wherein the polynucleotide molecules are of DNA.
7. Use of a device according to any of claims 1 to 6, in an analysis procedure to determine the sequence of the target polynucleotide.
8. Use according to claim 7, wherein the procedure is genotyping.
9. Use according to claim 7 or claim 8, wherein the target polynucleotides are individually resolved by optical microscopy.
10. A method for the preparation of a device according to any of claims 1 to
6. comprising ligating a target polynucleotide to the 5' end of a first molecule capable of forming a duplex as defined in claim 1 , and immobilising the first molecule to the solid surface either before or after ligation.
11. A method according to claim 10, wherein the immobilising is after the ligation of the target polynucleotide.
12. A method according to claim 10 or claim 1 1 , wherein the target polynucleotide is in the form of double-stranded DNA, ligation is between one strand of the DNA and the first molecule, and the other strand is removed after ligation.
13. A method according to claim 12, wherein a further polynucleotide is hybridised to the first molecule with a one or more base gap between the further polynucleotide and the 3'-end of the first molecule, ligation is between the double-stranded DNA and the 5'-end of the first molecule and the further polynucleotide and hybridisation is subsequently disrupted to remove the further polynucleotide to form the target polynucleotide.
14. A method according to any of claims 10 to 13, wherein the 5'-end of the first duplex is phosphorylated and the target polynucleotide is dephosphorylated prior to ligation.
PCT/GB2001/000407 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing WO2001057248A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002398168A CA2398168A1 (en) 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing
IL15083601A IL150836A0 (en) 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing
JP2001555871A JP2003521693A (en) 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing
AU30384/01A AU3038401A (en) 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing
EP01902529A EP1252332A2 (en) 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing
IS6489A IS6489A (en) 2000-02-01 2002-07-31 Multicore arrays and their use in sequencing
HK02109277.3A HK1047771A1 (en) 2000-02-01 2002-12-23 Polynucleotide arrays and their use in sequencing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0002310.1 2000-02-01
GBGB0002310.1A GB0002310D0 (en) 2000-02-01 2000-02-01 Polynucleotide sequencing

Publications (2)

Publication Number Publication Date
WO2001057248A2 true WO2001057248A2 (en) 2001-08-09
WO2001057248A3 WO2001057248A3 (en) 2002-02-14

Family

ID=9884765

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/000407 WO2001057248A2 (en) 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing

Country Status (9)

Country Link
EP (1) EP1252332A2 (en)
JP (1) JP2003521693A (en)
AU (1) AU3038401A (en)
CA (1) CA2398168A1 (en)
GB (1) GB0002310D0 (en)
HK (1) HK1047771A1 (en)
IL (1) IL150836A0 (en)
IS (1) IS6489A (en)
WO (1) WO2001057248A2 (en)

Cited By (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061127A2 (en) * 2001-01-30 2002-08-08 Solexa Ltd. Arrayed polynucleotides and their use in genome analysis
WO2002074988A2 (en) * 2001-03-16 2002-09-26 The Chancellor, Master And Scholars Of The University Of Oxford Arrays and methods of use
WO2003016565A2 (en) * 2001-08-13 2003-02-27 Solexa Ltd Dna sequence analysis
WO2004027093A1 (en) * 2002-09-19 2004-04-01 The Chancellor, Master And Scholars Of The University Of Oxford Molecular arrays and single molecule detection
WO2004076692A1 (en) * 2003-02-26 2004-09-10 Solexa Limited Dna sequence analysis
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
WO2005044836A2 (en) 2003-11-05 2005-05-19 Genovoxx Gmbh Macromolecular nucleotide compounds and methods for using the same
US7033764B2 (en) 1999-05-19 2006-04-25 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
EP1739192A1 (en) * 2005-07-01 2007-01-03 Agilent Technologies, Inc. Nucleic acid probes for analysis of small RNAs and other polynucleotides
US7170050B2 (en) 2004-09-17 2007-01-30 Pacific Biosciences Of California, Inc. Apparatus and methods for optical analysis of molecules
WO2007018601A1 (en) * 2005-08-02 2007-02-15 Rubicon Genomics, Inc. Compositions and methods for processing and amplification of dna, including using multiple enzymes in a single reaction
US7427673B2 (en) 2001-12-04 2008-09-23 Illumina Cambridge Limited Labelled nucleotides
US7541444B2 (en) 2002-08-23 2009-06-02 Illumina Cambridge Limited Modified nucleotides
US7592435B2 (en) 2005-08-19 2009-09-22 Illumina Cambridge Limited Modified nucleosides and nucleotides and uses thereof
WO2009116863A2 (en) 2008-03-17 2009-09-24 Expressive Research B.V. Expression-linked gene discovery
US7645596B2 (en) 1998-05-01 2010-01-12 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
EP2182079A1 (en) 2006-07-12 2010-05-05 Keygene N.V. High throughput physical mapping using AFLP
EP2189540A1 (en) 2005-07-20 2010-05-26 Illumina Cambridge Limited Methods for sequencing a polynucleotide template
US7754475B2 (en) 2006-01-25 2010-07-13 Agilent Technologies, Inc. Nucleic acid probes and microarrays for analysis of polynucleotides
WO2010082815A1 (en) 2009-01-13 2010-07-22 Keygene N.V. Novel genome sequencing strategies
US7772384B2 (en) 2001-12-04 2010-08-10 Illumina Cambridge Limited Labelled nucleotides
EP2270206A2 (en) 2003-10-20 2011-01-05 Isis Innovation Ltd Nucleic acid sequencing methods
US7897345B2 (en) 2003-11-12 2011-03-01 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
EP2336315A2 (en) 2005-12-01 2011-06-22 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US7981604B2 (en) 2004-02-19 2011-07-19 California Institute Of Technology Methods and kits for analyzing polynucleotide sequences
WO2012034007A2 (en) 2010-09-10 2012-03-15 Bio-Rad Laboratories, Inc. Size selection of dna for chromatin analysis
WO2013009175A1 (en) 2011-07-08 2013-01-17 Keygene N.V. Sequence based genotyping based on oligonucleotide ligation assays
WO2014135221A1 (en) 2013-03-08 2014-09-12 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
WO2014135669A1 (en) 2013-03-08 2014-09-12 Roche Diagnostics Gmbh Egfr mutation blood testing
WO2014135223A1 (en) 2013-03-08 2014-09-12 Illumina Cambridge Ltd Rhodamine compounds and their use as fluorescent labels
WO2014181115A2 (en) 2013-05-08 2014-11-13 Iles Ray Kruse Cgb2 and cgb1 genes; diagnosis, monitoring and treatment of cancer
US9051612B2 (en) 2006-09-28 2015-06-09 Illumina, Inc. Compositions and methods for nucleotide sequencing
US9096898B2 (en) 1998-05-01 2015-08-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
US9212394B2 (en) 2013-08-19 2015-12-15 Singular Bio, Inc. Assays for single molecule detection and use thereof
EP2963127A1 (en) 2006-04-04 2016-01-06 Keygene N.V. High throughput detection of molecular markers based on restriction fragments
US9347093B2 (en) 2011-11-17 2016-05-24 Vilnius University Nucleic acid production and sequence analysis
EP1907583B1 (en) 2005-06-15 2016-10-05 Complete Genomics Inc. Single molecule arrays for genetic and chemical analysis
US9650628B2 (en) 2012-01-26 2017-05-16 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library regeneration
WO2017087823A1 (en) 2015-11-18 2017-05-26 Mir Kalim U Super-resolution sequencing
US9670539B2 (en) 2007-10-19 2017-06-06 The Trustees Of Columbia University In The City Of New York Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis
US20170166961A1 (en) 2013-03-15 2017-06-15 Illumina Cambridge Limited Modified nucleosides or nucleotides
US20170175185A1 (en) * 2005-03-29 2017-06-22 Applied Biosystems, Llc Nanowire-based system for analysis of nucleic acids
US9708358B2 (en) 2000-10-06 2017-07-18 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US9718852B2 (en) 2000-10-06 2017-08-01 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
EP3170904B1 (en) 2008-03-28 2017-08-16 Pacific Biosciences Of California, Inc. Compositions and methods for nucleic acid sequencing
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
US9822408B2 (en) 2013-03-15 2017-11-21 Nugen Technologies, Inc. Sequential sequencing
US9868982B2 (en) 2007-02-07 2018-01-16 Illumina Cambridge Limited Preparation of templates for methylation analysis
WO2018060482A1 (en) 2016-09-30 2018-04-05 Illumina Cambridge Limited New fluorescent dyes and their uses as biomarkers
US9957549B2 (en) 2012-06-18 2018-05-01 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
WO2018114710A1 (en) 2016-12-22 2018-06-28 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
WO2018148723A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from pyrococcus abyssi
WO2018148724A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from pyrococcus furiosus
WO2018148726A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from phage t4
WO2018148727A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from 9°n
US10102337B2 (en) 2014-08-06 2018-10-16 Nugen Technologies, Inc. Digital measurements from targeted sequencing
US10239909B2 (en) 2015-05-22 2019-03-26 Illumina Cambridge Limited Polymethine compounds with long stokes shifts and their use as fluorescent labels
US10260094B2 (en) 2007-10-19 2019-04-16 The Trustees Of Columbia University In The City Of New York DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators
US10465232B1 (en) 2015-10-08 2019-11-05 Trace Genomics, Inc. Methods for quantifying efficiency of nucleic acid extraction and detection
US10487102B2 (en) 2002-08-23 2019-11-26 Illumina Cambridge Limited Labelled nucleotides
US10526648B2 (en) 2017-07-12 2020-01-07 Illumina Cambridge Limited Short pendant arm linkers for nucleotides in sequencing applications
US10570448B2 (en) 2013-11-13 2020-02-25 Tecan Genomics Compositions and methods for identification of a duplicate sequencing read
US10648026B2 (en) 2013-03-15 2020-05-12 The Trustees Of Columbia University In The City Of New York Raman cluster tagged molecules for biological imaging
EP3663290A1 (en) 2015-09-25 2020-06-10 Illumina Cambridge Limited Polymethine compounds and their use as fluorescent labels
WO2020136170A2 (en) 2018-12-26 2020-07-02 Illumina Cambridge Limited Nucleosides and nucleotides with 3'-hydroxy blocking groups
WO2020178231A1 (en) 2019-03-01 2020-09-10 Illumina, Inc. Multiplexed fluorescent detection of analytes
WO2020178165A1 (en) 2019-03-01 2020-09-10 Illumina Cambridge Limited Tertiary amine substituted coumarin compounds and their uses as fluorescent labels
WO2020178162A1 (en) 2019-03-01 2020-09-10 Illumina Cambridge Limited Exocyclic amine-substituted coumarin compounds and their uses as fluorescent labels
NL2023327B1 (en) 2019-03-01 2020-09-17 Illumina Inc Multiplexed fluorescent detection of analytes
WO2020193765A1 (en) 2019-03-28 2020-10-01 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing using photoswitchable labels
US10995111B2 (en) 2003-08-22 2021-05-04 Illumina Cambridge Limited Labelled nucleotides
EP3828167A1 (en) 2014-05-07 2021-06-02 Illumina Cambridge Limited Polymethine compounds and their use as fluorescent labels
WO2021104845A1 (en) 2019-11-27 2021-06-03 Illumina Cambridge Limited Cyclooctatetraene containing dyes and compositions
US11028430B2 (en) 2012-07-09 2021-06-08 Nugen Technologies, Inc. Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
US11098353B2 (en) 2006-12-01 2021-08-24 The Trustees Of Columbia University In The City Of New York Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
WO2021259881A1 (en) 2020-06-22 2021-12-30 Illumina Cambridge Limited Nucleosides and nucleotides with 3' acetal blocking group
WO2022023353A1 (en) 2020-07-28 2022-02-03 Illumina Cambridge Limited Substituted coumarin dyes and uses as fluorescent labels
EP4006150A1 (en) 2015-09-09 2022-06-01 QIAGEN GmbH Polymerase enzyme
WO2022129930A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Alkylpyridinium coumarin dyes and uses in sequencing applications
WO2022129437A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Long stokes shift chromenoquinoline dyes and uses in sequencing applications
WO2022129439A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Methods, systems and compositions for nucleic acid sequencing
WO2022136402A1 (en) 2020-12-22 2022-06-30 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing
US11390619B2 (en) 2017-10-16 2022-07-19 Illumina Cambridge Limited Secondary amine-substituted coumarin compounds and their uses as fluorescent labels
WO2022233795A1 (en) 2021-05-05 2022-11-10 Illumina Cambridge Limited Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing
WO2022243480A1 (en) 2021-05-20 2022-11-24 Illumina, Inc. Compositions and methods for sequencing by synthesis
WO2023114896A1 (en) 2021-12-16 2023-06-22 Illumina Cambridge Limited Methods for metal directed cleavage of surface-bound polynucleotides
WO2023122491A1 (en) 2021-12-20 2023-06-29 Illumina Cambridge Limited Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides
WO2023122499A1 (en) 2021-12-20 2023-06-29 Illumina Cambridge Limited Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides
WO2023141154A1 (en) 2022-01-20 2023-07-27 Illumina Cambridge Limited Methods of detecting methylcytosine and hydroxymethylcytosine by sequencing
US11739371B2 (en) 2015-02-18 2023-08-29 Invitae Corporation Arrays for single molecule detection and use thereof
WO2023186815A1 (en) 2022-03-28 2023-10-05 Illumina Cambridge Limited Labeled avidin and methods for sequencing
WO2023186982A1 (en) 2022-03-31 2023-10-05 Illumina, Inc. Compositions and methods for improving sequencing signals
WO2023192163A1 (en) 2022-03-29 2023-10-05 Illumina Cambridge Limited Systems and methods of sequencing polynucleotides
WO2023192900A1 (en) 2022-03-31 2023-10-05 Illumina Singapore Pte. Ltd. Nucleosides and nucleotides with 3' vinyl blocking group useful in sequencing by synthesis
WO2023186872A1 (en) 2022-03-30 2023-10-05 Illumina Cambridge Limited Methods for chemical cleavage of surface-bound polynucleotides
WO2023232829A1 (en) 2022-05-31 2023-12-07 Illumina, Inc Compositions and methods for nucleic acid sequencing
WO2024003087A1 (en) 2022-06-28 2024-01-04 Illumina, Inc. Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing
US11866741B2 (en) 2017-02-13 2024-01-09 IsoPlexis Corporation Polymerase enzyme from 9°N
WO2024039516A1 (en) 2022-08-19 2024-02-22 Illumina, Inc. Third dna base pair site-specific dna detection
WO2024068889A2 (en) 2022-09-30 2024-04-04 Illumina, Inc. Compositions and methods for reducing photo damage during sequencing

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044425A2 (en) 2000-12-01 2002-06-06 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013666A1 (en) * 1989-05-11 1990-11-15 Amersham International Plc Sequencing method
EP0427073A2 (en) * 1989-11-09 1991-05-15 Miles Inc. Nucleic acid amplification employing ligatable hairpin probe and transcription
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
EP0721016A2 (en) * 1994-10-21 1996-07-10 Affymax Technologies N.V. Nucleic acid library arrays, methods for synthesizing them and methods for sequencing and sample screening using them
WO1996027025A1 (en) * 1995-02-27 1996-09-06 Ely Michael Rabani Device, compounds, algorithms, and methods of molecular characterization and manipulation with molecular parallelism
WO1997004131A1 (en) * 1995-07-21 1997-02-06 Forsyth Dental Infirmary For Children Single primer amplification of polynucleotide hairpins
WO1997008183A1 (en) * 1995-08-25 1997-03-06 Lane Michael J Nucleic acid capture moieties
WO1998003673A1 (en) * 1996-07-19 1998-01-29 Cornell Research Foundation, Inc. High fidelity detection of nucleic acid differences by ligase detection reaction
WO1998020019A1 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. Compositions and methods for immobilizing nucleic acids to solid supports
WO1999005321A1 (en) * 1997-07-22 1999-02-04 Rapigene, Inc. Amplification and other enzymatic reactions performed on nucleic acid arrays
WO1999028494A1 (en) * 1997-12-04 1999-06-10 Packard Bioscience Company Methods of using probes for analyzing polynucleotide sequence
EP0995804A2 (en) * 1998-09-15 2000-04-26 Affymetrix, Inc. (a California Corporation) Nucleic acid analysis using complete N-mer arrays
WO2001025485A2 (en) * 1999-10-06 2001-04-12 Amersham Biosciences Corp Method for detecting mutations using arrayed primer extension

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013666A1 (en) * 1989-05-11 1990-11-15 Amersham International Plc Sequencing method
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
EP0427073A2 (en) * 1989-11-09 1991-05-15 Miles Inc. Nucleic acid amplification employing ligatable hairpin probe and transcription
EP0721016A2 (en) * 1994-10-21 1996-07-10 Affymax Technologies N.V. Nucleic acid library arrays, methods for synthesizing them and methods for sequencing and sample screening using them
WO1996027025A1 (en) * 1995-02-27 1996-09-06 Ely Michael Rabani Device, compounds, algorithms, and methods of molecular characterization and manipulation with molecular parallelism
WO1997004131A1 (en) * 1995-07-21 1997-02-06 Forsyth Dental Infirmary For Children Single primer amplification of polynucleotide hairpins
WO1997008183A1 (en) * 1995-08-25 1997-03-06 Lane Michael J Nucleic acid capture moieties
WO1998003673A1 (en) * 1996-07-19 1998-01-29 Cornell Research Foundation, Inc. High fidelity detection of nucleic acid differences by ligase detection reaction
WO1998020019A1 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. Compositions and methods for immobilizing nucleic acids to solid supports
WO1999005321A1 (en) * 1997-07-22 1999-02-04 Rapigene, Inc. Amplification and other enzymatic reactions performed on nucleic acid arrays
WO1999028494A1 (en) * 1997-12-04 1999-06-10 Packard Bioscience Company Methods of using probes for analyzing polynucleotide sequence
EP0995804A2 (en) * 1998-09-15 2000-04-26 Affymetrix, Inc. (a California Corporation) Nucleic acid analysis using complete N-mer arrays
WO2001025485A2 (en) * 1999-10-06 2001-04-12 Amersham Biosciences Corp Method for detecting mutations using arrayed primer extension

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BROUDE N E ET AL: "ENHANCED DNA SEQUENCING BY HYBRIDIZATION" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 91, 1 April 1994 (1994-04-01), pages 3072-3076, XP000619675 ISSN: 0027-8424 *
PASTINEN T ET AL: "MINISEQUENCING: A SPECIFIC TOOL FOR DNA ANALYSIS AND DIAGNOSTICS ON OLIGONUCLEOTIDE ARRAYS" PCR METHODS AND APPLICATIONS, COLD SPRING HARBOR, NY, US, 1997, pages 606-614, XP002930983 ISSN: 1054-9803 *
ZHAO XIAODONG ET AL: "Immobilization of oligodeoxyribonucleotides with multiple anchors to microchips." NUCLEIC ACIDS RESEARCH, vol. 29, no. 4, 15 February 2001 (2001-02-15), pages 955-959, XP002175040 ISSN: 0305-1048 *

Cited By (225)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645596B2 (en) 1998-05-01 2010-01-12 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9725764B2 (en) 1998-05-01 2017-08-08 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9957561B2 (en) 1998-05-01 2018-05-01 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US10208341B2 (en) 1998-05-01 2019-02-19 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9458500B2 (en) 1998-05-01 2016-10-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US10214774B2 (en) 1998-05-01 2019-02-26 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9212393B2 (en) 1998-05-01 2015-12-15 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9096898B2 (en) 1998-05-01 2015-08-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7943305B2 (en) 1999-05-19 2011-05-17 Cornell Research Foundation High speed nucleic acid sequencing
US7943307B2 (en) 1999-05-19 2011-05-17 Cornell Research Foundation Methods for analyzing nucleic acid sequences
US7033764B2 (en) 1999-05-19 2006-04-25 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US7052847B2 (en) 1999-05-19 2006-05-30 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US7056661B2 (en) 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US7056676B2 (en) 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US7361466B2 (en) 1999-05-19 2008-04-22 Cornell Research Foundation, Inc. Nucleic acid analysis using terminal-phosphate-labeled nucleotides
US7485424B2 (en) 1999-05-19 2009-02-03 Cornell Research Foundation, Inc. Labeled nucleotide phosphate (NP) probes
US7416844B2 (en) 1999-05-19 2008-08-26 Cornell Research Foundation, Inc. Composition for nucleic acid sequencing
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US10407459B2 (en) 2000-10-06 2019-09-10 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10428380B2 (en) 2000-10-06 2019-10-01 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10648028B2 (en) 2000-10-06 2020-05-12 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US9725480B2 (en) 2000-10-06 2017-08-08 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US9719139B2 (en) 2000-10-06 2017-08-01 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US9718852B2 (en) 2000-10-06 2017-08-01 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US9708358B2 (en) 2000-10-06 2017-07-18 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US9868985B2 (en) 2000-10-06 2018-01-16 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10662472B2 (en) 2000-10-06 2020-05-26 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10577652B2 (en) 2000-10-06 2020-03-03 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10570446B2 (en) 2000-10-06 2020-02-25 The Trustee Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10457984B2 (en) 2000-10-06 2019-10-29 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10669582B2 (en) 2000-10-06 2020-06-02 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10435742B2 (en) 2000-10-06 2019-10-08 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10633700B2 (en) 2000-10-06 2020-04-28 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10407458B2 (en) 2000-10-06 2019-09-10 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US10669577B2 (en) 2000-10-06 2020-06-02 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
GB2389904A (en) * 2001-01-30 2003-12-24 Solexa Ltd Arrayed polynucleotides and their use in genome analysis
WO2002061127A3 (en) * 2001-01-30 2003-07-24 Solexa Ltd Arrayed polynucleotides and their use in genome analysis
WO2002061127A2 (en) * 2001-01-30 2002-08-08 Solexa Ltd. Arrayed polynucleotides and their use in genome analysis
US9057730B2 (en) 2001-03-16 2015-06-16 Singular Bio, Inc. Arrays and methods of use
US9376677B2 (en) 2001-03-16 2016-06-28 Singular Bio, Inc. Arrays and methods of use
WO2002074988A3 (en) * 2001-03-16 2003-08-14 Chancellor Master And Scholars Arrays and methods of use
US9481883B2 (en) 2001-03-16 2016-11-01 Singular Bio, Inc. Arrays and methods of use
WO2002074988A2 (en) * 2001-03-16 2002-09-26 The Chancellor, Master And Scholars Of The University Of Oxford Arrays and methods of use
WO2003016565A3 (en) * 2001-08-13 2003-08-21 Solexa Ltd Dna sequence analysis
WO2003016565A2 (en) * 2001-08-13 2003-02-27 Solexa Ltd Dna sequence analysis
US7785796B2 (en) 2001-12-04 2010-08-31 Illumina Cambridge Limited Labelled nucleotides
US10480025B2 (en) 2001-12-04 2019-11-19 Illumina Cambridge Limited Labelled nucleotides
US7566537B2 (en) 2001-12-04 2009-07-28 Illumina Cambridge Limited Labelled nucleotides
US7772384B2 (en) 2001-12-04 2010-08-10 Illumina Cambridge Limited Labelled nucleotides
US7427673B2 (en) 2001-12-04 2008-09-23 Illumina Cambridge Limited Labelled nucleotides
US8148064B2 (en) 2001-12-04 2012-04-03 Illumina Cambridge Limited Labelled nucleotides
US8158346B2 (en) 2001-12-04 2012-04-17 Illumina Cambridge Limited Labelled nucleotides
US9605310B2 (en) 2001-12-04 2017-03-28 Illumina Cambridge Limited Labelled nucleotides
US10519496B2 (en) 2001-12-04 2019-12-31 Illumina Cambridge Limited Labelled nucleotides
US10513731B2 (en) 2002-08-23 2019-12-24 Illumina Cambridge Limited Modified nucleotides
US10487102B2 (en) 2002-08-23 2019-11-26 Illumina Cambridge Limited Labelled nucleotides
US11008359B2 (en) 2002-08-23 2021-05-18 Illumina Cambridge Limited Labelled nucleotides
US7541444B2 (en) 2002-08-23 2009-06-02 Illumina Cambridge Limited Modified nucleotides
US8071739B2 (en) 2002-08-23 2011-12-06 Illumina Cambridge Limited Modified nucleotides
WO2004027093A1 (en) * 2002-09-19 2004-04-01 The Chancellor, Master And Scholars Of The University Of Oxford Molecular arrays and single molecule detection
US7771973B2 (en) 2002-12-23 2010-08-10 Illumina Cambridge Limited Modified nucleotides
WO2004076692A1 (en) * 2003-02-26 2004-09-10 Solexa Limited Dna sequence analysis
US7351532B2 (en) 2003-02-26 2008-04-01 Solexa Limited DNA sequence analysis
US11028116B2 (en) 2003-08-22 2021-06-08 Illumina Cambridge Limited Labelled nucleotides
US10995111B2 (en) 2003-08-22 2021-05-04 Illumina Cambridge Limited Labelled nucleotides
US11028115B2 (en) 2003-08-22 2021-06-08 Illumina Cambridge Limited Labelled nucleotides
EP2270206A2 (en) 2003-10-20 2011-01-05 Isis Innovation Ltd Nucleic acid sequencing methods
EP2270205A2 (en) 2003-10-20 2011-01-05 Isis Innovation Ltd Nucleic acid sequencing methods
EP2431481A1 (en) 2003-10-20 2012-03-21 Kalim Mir Parallel polymer sequencing methods
WO2005044836A2 (en) 2003-11-05 2005-05-19 Genovoxx Gmbh Macromolecular nucleotide compounds and methods for using the same
US9657344B2 (en) 2003-11-12 2017-05-23 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US7897345B2 (en) 2003-11-12 2011-03-01 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US9012144B2 (en) 2003-11-12 2015-04-21 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US7981604B2 (en) 2004-02-19 2011-07-19 California Institute Of Technology Methods and kits for analyzing polynucleotide sequences
US7170050B2 (en) 2004-09-17 2007-01-30 Pacific Biosciences Of California, Inc. Apparatus and methods for optical analysis of molecules
US9709503B2 (en) 2004-09-17 2017-07-18 Pacific Biosciences Of California, Inc. Apparatus and method for performing nucleic acid analysis
US20170175185A1 (en) * 2005-03-29 2017-06-22 Applied Biosystems, Llc Nanowire-based system for analysis of nucleic acids
US10415090B2 (en) * 2005-03-29 2019-09-17 Applied Biosystems, Llc Nanowire-based system for analysis of nucleic acids
US10961575B2 (en) 2005-03-29 2021-03-30 Applied Biosystems, Llc Nanowire-based system for analysis of nucleic acids
EP1907583B2 (en) † 2005-06-15 2019-10-23 Complete Genomics Inc. Single molecule arrays for genetic and chemical analysis
US9944984B2 (en) 2005-06-15 2018-04-17 Complete Genomics, Inc. High density DNA array
EP2620510B1 (en) 2005-06-15 2016-10-12 Complete Genomics Inc. Single molecule arrays for genetic and chemical analysis
US10351909B2 (en) 2005-06-15 2019-07-16 Complete Genomics, Inc. DNA sequencing from high density DNA arrays using asynchronous reactions
EP1907583B1 (en) 2005-06-15 2016-10-05 Complete Genomics Inc. Single molecule arrays for genetic and chemical analysis
US9297036B2 (en) 2005-07-01 2016-03-29 Agilent Technologies, Inc Nucleic acid probes for analysis of small RNAs and other polynucleotides
EP1739192A1 (en) * 2005-07-01 2007-01-03 Agilent Technologies, Inc. Nucleic acid probes for analysis of small RNAs and other polynucleotides
US9765391B2 (en) 2005-07-20 2017-09-19 Illumina Cambridge Limited Methods for sequencing a polynucleotide template
US10793904B2 (en) 2005-07-20 2020-10-06 Illumina Cambridge Limited Methods for sequencing a polynucleotide template
EP2189540A1 (en) 2005-07-20 2010-05-26 Illumina Cambridge Limited Methods for sequencing a polynucleotide template
US11542553B2 (en) 2005-07-20 2023-01-03 Illumina Cambridge Limited Methods for sequencing a polynucleotide template
US10208337B2 (en) 2005-08-02 2019-02-19 Takara Bio Usa, Inc. Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
US8728737B2 (en) 2005-08-02 2014-05-20 Rubicon Genomics, Inc. Attaching a stem-loop oligonucleotide to a double stranded DNA molecule
WO2007018601A1 (en) * 2005-08-02 2007-02-15 Rubicon Genomics, Inc. Compositions and methods for processing and amplification of dna, including using multiple enzymes in a single reaction
US9598727B2 (en) 2005-08-02 2017-03-21 Rubicon Genomics, Inc. Methods for processing and amplifying nucleic acids
US11072823B2 (en) 2005-08-02 2021-07-27 Takara Bio Usa, Inc. Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
US10196686B2 (en) 2005-08-02 2019-02-05 Takara Bio Usa, Inc. Kits including stem-loop oligonucleotides for use in preparing nucleic acid molecules
US8399199B2 (en) 2005-08-02 2013-03-19 Rubicon Genomics Use of stem-loop oligonucleotides in the preparation of nucleic acid molecules
US8071312B2 (en) 2005-08-02 2011-12-06 Rubicon Genomics, Inc. Methods for producing and using stem-loop oligonucleotides
US7803550B2 (en) 2005-08-02 2010-09-28 Rubicon Genomics, Inc. Methods of producing nucleic acid molecules comprising stem loop oligonucleotides
US7592435B2 (en) 2005-08-19 2009-09-22 Illumina Cambridge Limited Modified nucleosides and nucleotides and uses thereof
US9868978B2 (en) 2005-08-26 2018-01-16 Fluidigm Corporation Single molecule sequencing of captured nucleic acids
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
EP3305900A1 (en) 2005-12-01 2018-04-11 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
EP2336315A2 (en) 2005-12-01 2011-06-22 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
EP2341140A1 (en) 2005-12-01 2011-07-06 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US7754475B2 (en) 2006-01-25 2010-07-13 Agilent Technologies, Inc. Nucleic acid probes and microarrays for analysis of polynucleotides
EP2963127A1 (en) 2006-04-04 2016-01-06 Keygene N.V. High throughput detection of molecular markers based on restriction fragments
EP2182079A1 (en) 2006-07-12 2010-05-05 Keygene N.V. High throughput physical mapping using AFLP
EP2275576A1 (en) 2006-07-12 2011-01-19 Keygene N.V. High throughput physical mapping using AFLP
EP2821506A1 (en) 2006-07-12 2015-01-07 Keygene N.V. Identification of clones by sequencing of pool-specific adapters
US9051612B2 (en) 2006-09-28 2015-06-09 Illumina, Inc. Compositions and methods for nucleotide sequencing
US11098353B2 (en) 2006-12-01 2021-08-24 The Trustees Of Columbia University In The City Of New York Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
US11939631B2 (en) 2006-12-01 2024-03-26 The Trustees Of Columbia University In The City Of New York Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
US10954554B2 (en) 2007-02-07 2021-03-23 Illumina Cambridge Limited Preparation of templates for methylation analysis
US11827927B2 (en) 2007-02-07 2023-11-28 Illumina Cambridge Limited Preparation of templates for methylation analysis
US9868982B2 (en) 2007-02-07 2018-01-16 Illumina Cambridge Limited Preparation of templates for methylation analysis
US9670539B2 (en) 2007-10-19 2017-06-06 The Trustees Of Columbia University In The City Of New York Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis
US10260094B2 (en) 2007-10-19 2019-04-16 The Trustees Of Columbia University In The City Of New York DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators
US10144961B2 (en) 2007-10-19 2018-12-04 The Trustees Of Columbia University In The City Of New York Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis
US11208691B2 (en) 2007-10-19 2021-12-28 The Trustees Of Columbia University In The City Of New York Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis
US11242561B2 (en) 2007-10-19 2022-02-08 The Trustees Of Columbia University In The City Of New York DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators
WO2009116863A2 (en) 2008-03-17 2009-09-24 Expressive Research B.V. Expression-linked gene discovery
US11705217B2 (en) 2008-03-28 2023-07-18 Pacific Biosciences Of California, Inc. Sequencing using concatemers of copies of sense and antisense strands
EP3170904B1 (en) 2008-03-28 2017-08-16 Pacific Biosciences Of California, Inc. Compositions and methods for nucleic acid sequencing
WO2010082815A1 (en) 2009-01-13 2010-07-22 Keygene N.V. Novel genome sequencing strategies
WO2012034007A2 (en) 2010-09-10 2012-03-15 Bio-Rad Laboratories, Inc. Size selection of dna for chromatin analysis
EP2980226A1 (en) 2011-07-08 2016-02-03 Keygene N.V. Sequence based genotyping based on oligonucleotide ligation assays
WO2013009175A1 (en) 2011-07-08 2013-01-17 Keygene N.V. Sequence based genotyping based on oligonucleotide ligation assays
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
US9347093B2 (en) 2011-11-17 2016-05-24 Vilnius University Nucleic acid production and sequence analysis
US9988673B2 (en) 2011-11-17 2018-06-05 Vilnius University Nucleic acid production and sequence analysis
US9650628B2 (en) 2012-01-26 2017-05-16 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library regeneration
US10876108B2 (en) 2012-01-26 2020-12-29 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
US10036012B2 (en) 2012-01-26 2018-07-31 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
US9957549B2 (en) 2012-06-18 2018-05-01 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US11697843B2 (en) 2012-07-09 2023-07-11 Tecan Genomics, Inc. Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US11028430B2 (en) 2012-07-09 2021-06-08 Nugen Technologies, Inc. Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
WO2014135669A1 (en) 2013-03-08 2014-09-12 Roche Diagnostics Gmbh Egfr mutation blood testing
WO2014135221A1 (en) 2013-03-08 2014-09-12 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
WO2014135223A1 (en) 2013-03-08 2014-09-12 Illumina Cambridge Ltd Rhodamine compounds and their use as fluorescent labels
US9822408B2 (en) 2013-03-15 2017-11-21 Nugen Technologies, Inc. Sequential sequencing
US10619206B2 (en) 2013-03-15 2020-04-14 Tecan Genomics Sequential sequencing
US10982277B2 (en) 2013-03-15 2021-04-20 Illumina Cambridge Limited Modified nucleosides or nucleotides
US20170166961A1 (en) 2013-03-15 2017-06-15 Illumina Cambridge Limited Modified nucleosides or nucleotides
US10648026B2 (en) 2013-03-15 2020-05-12 The Trustees Of Columbia University In The City Of New York Raman cluster tagged molecules for biological imaging
US10407721B2 (en) 2013-03-15 2019-09-10 Illumina Cambridge Limited Modified nucleosides or nucleotides
US10760123B2 (en) 2013-03-15 2020-09-01 Nugen Technologies, Inc. Sequential sequencing
WO2014181115A2 (en) 2013-05-08 2014-11-13 Iles Ray Kruse Cgb2 and cgb1 genes; diagnosis, monitoring and treatment of cancer
US9758814B2 (en) 2013-08-19 2017-09-12 Singular Bio, Inc. Assays for single molecule detection and use thereof
US9212394B2 (en) 2013-08-19 2015-12-15 Singular Bio, Inc. Assays for single molecule detection and use thereof
US11326204B2 (en) 2013-08-19 2022-05-10 Invitae Corporation Assays for single molecule detection and use thereof
US10626450B2 (en) 2013-08-19 2020-04-21 Singular Bio, Inc. Assays for single molecule detection and use thereof
US11725241B2 (en) 2013-11-13 2023-08-15 Tecan Genomics, Inc. Compositions and methods for identification of a duplicate sequencing read
US11098357B2 (en) 2013-11-13 2021-08-24 Tecan Genomics, Inc. Compositions and methods for identification of a duplicate sequencing read
US10570448B2 (en) 2013-11-13 2020-02-25 Tecan Genomics Compositions and methods for identification of a duplicate sequencing read
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
EP3828167A1 (en) 2014-05-07 2021-06-02 Illumina Cambridge Limited Polymethine compounds and their use as fluorescent labels
US10102337B2 (en) 2014-08-06 2018-10-16 Nugen Technologies, Inc. Digital measurements from targeted sequencing
US11739371B2 (en) 2015-02-18 2023-08-29 Invitae Corporation Arrays for single molecule detection and use thereof
US10239909B2 (en) 2015-05-22 2019-03-26 Illumina Cambridge Limited Polymethine compounds with long stokes shifts and their use as fluorescent labels
EP4006150A1 (en) 2015-09-09 2022-06-01 QIAGEN GmbH Polymerase enzyme
US10982261B2 (en) 2015-09-25 2021-04-20 Illumina Cambridge Limited Polymethine compounds and their use as fluorescent labels
EP3831825A1 (en) 2015-09-25 2021-06-09 Illumina Cambridge Limited Polymethine compounds and their use as fluorescent labels
US11530439B2 (en) 2015-09-25 2022-12-20 Illumina Cambridge Limited Polymethine compounds and their use as fluorescent labels
EP3663290A1 (en) 2015-09-25 2020-06-10 Illumina Cambridge Limited Polymethine compounds and their use as fluorescent labels
US10465232B1 (en) 2015-10-08 2019-11-05 Trace Genomics, Inc. Methods for quantifying efficiency of nucleic acid extraction and detection
WO2017087823A1 (en) 2015-11-18 2017-05-26 Mir Kalim U Super-resolution sequencing
US10844225B2 (en) 2016-09-30 2020-11-24 Illumina Cambridge Limited Fluorescent dyes and their uses as biomarkers
WO2018060482A1 (en) 2016-09-30 2018-04-05 Illumina Cambridge Limited New fluorescent dyes and their uses as biomarkers
US11370920B2 (en) 2016-09-30 2022-06-28 Illumina Cambridge Limited Fluorescent dyes and their uses as biomarkers
EP3974425A1 (en) 2016-09-30 2022-03-30 Illumina Cambridge Limited New fluorescent dyes and their uses as biomarkers
US10385214B2 (en) 2016-09-30 2019-08-20 Illumina Cambridge Limited Fluorescent dyes and their uses as biomarkers
US10214768B2 (en) 2016-12-22 2019-02-26 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
US10907196B2 (en) 2016-12-22 2021-02-02 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
US10533211B2 (en) 2016-12-22 2020-01-14 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
WO2018114710A1 (en) 2016-12-22 2018-06-28 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
EP4257596A2 (en) 2016-12-22 2023-10-11 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
US11371078B2 (en) 2016-12-22 2022-06-28 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
WO2018148723A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from pyrococcus abyssi
WO2018148727A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from 9°n
WO2018148726A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from phage t4
WO2018148724A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from pyrococcus furiosus
US11866741B2 (en) 2017-02-13 2024-01-09 IsoPlexis Corporation Polymerase enzyme from 9°N
US10526648B2 (en) 2017-07-12 2020-01-07 Illumina Cambridge Limited Short pendant arm linkers for nucleotides in sequencing applications
US11001888B2 (en) 2017-07-12 2021-05-11 Illumina Cambridge Limited Short pendant arm linkers for nucleotides in sequencing applications
US11655502B2 (en) 2017-07-12 2023-05-23 Illumina Cambridge Limited Short pendant arm linkers for nucleotides in sequencing applications
US11858923B2 (en) 2017-10-16 2024-01-02 Illumina Cambridge Limited Secondary amine-substituted coumarin compounds and their uses as fluorescent labels
US11390619B2 (en) 2017-10-16 2022-07-19 Illumina Cambridge Limited Secondary amine-substituted coumarin compounds and their uses as fluorescent labels
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
US11827931B2 (en) 2018-12-26 2023-11-28 Illumina Cambridge Limited Methods of preparing growing polynucleotides using nucleotides with 3′ AOM blocking group
US11293061B2 (en) 2018-12-26 2022-04-05 Illumina Cambridge Limited Sequencing methods using nucleotides with 3′ AOM blocking group
WO2020136170A2 (en) 2018-12-26 2020-07-02 Illumina Cambridge Limited Nucleosides and nucleotides with 3'-hydroxy blocking groups
WO2020178231A1 (en) 2019-03-01 2020-09-10 Illumina, Inc. Multiplexed fluorescent detection of analytes
WO2020178165A1 (en) 2019-03-01 2020-09-10 Illumina Cambridge Limited Tertiary amine substituted coumarin compounds and their uses as fluorescent labels
US11390753B2 (en) 2019-03-01 2022-07-19 Illumina Cambridge Limited Exocyclic amine substituted coumarin compounds and uses as fluorescent labels
WO2020178162A1 (en) 2019-03-01 2020-09-10 Illumina Cambridge Limited Exocyclic amine-substituted coumarin compounds and their uses as fluorescent labels
NL2023327B1 (en) 2019-03-01 2020-09-17 Illumina Inc Multiplexed fluorescent detection of analytes
US11884825B2 (en) 2019-03-01 2024-01-30 Illumina Cambridge Limited Exocyclic amine substituted coumarin compounds and uses as fluorescent labels
US11421271B2 (en) 2019-03-28 2022-08-23 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing using photoswitchable labels
WO2020193765A1 (en) 2019-03-28 2020-10-01 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing using photoswitchable labels
US11597969B2 (en) 2019-11-27 2023-03-07 Illumina Cambridge Limited Cyclooctatetraene containing dyes and compositions
WO2021104845A1 (en) 2019-11-27 2021-06-03 Illumina Cambridge Limited Cyclooctatetraene containing dyes and compositions
WO2021259881A1 (en) 2020-06-22 2021-12-30 Illumina Cambridge Limited Nucleosides and nucleotides with 3' acetal blocking group
US11787831B2 (en) 2020-06-22 2023-10-17 Illumina Cambridge Limited Nucleosides and nucleotides with 3′ acetal blocking group
WO2022023353A1 (en) 2020-07-28 2022-02-03 Illumina Cambridge Limited Substituted coumarin dyes and uses as fluorescent labels
WO2022129930A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Alkylpyridinium coumarin dyes and uses in sequencing applications
WO2022129439A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Methods, systems and compositions for nucleic acid sequencing
WO2022129437A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Long stokes shift chromenoquinoline dyes and uses in sequencing applications
WO2022136402A1 (en) 2020-12-22 2022-06-30 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing
WO2022233795A1 (en) 2021-05-05 2022-11-10 Illumina Cambridge Limited Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing
WO2022243480A1 (en) 2021-05-20 2022-11-24 Illumina, Inc. Compositions and methods for sequencing by synthesis
WO2023114896A1 (en) 2021-12-16 2023-06-22 Illumina Cambridge Limited Methods for metal directed cleavage of surface-bound polynucleotides
WO2023122491A1 (en) 2021-12-20 2023-06-29 Illumina Cambridge Limited Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides
WO2023122499A1 (en) 2021-12-20 2023-06-29 Illumina Cambridge Limited Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides
WO2023141154A1 (en) 2022-01-20 2023-07-27 Illumina Cambridge Limited Methods of detecting methylcytosine and hydroxymethylcytosine by sequencing
WO2023186815A1 (en) 2022-03-28 2023-10-05 Illumina Cambridge Limited Labeled avidin and methods for sequencing
WO2023192163A1 (en) 2022-03-29 2023-10-05 Illumina Cambridge Limited Systems and methods of sequencing polynucleotides
WO2023186819A1 (en) 2022-03-29 2023-10-05 Illumina Cambridge Limited Chromenoquinoline dyes and uses in sequencing
WO2023186872A1 (en) 2022-03-30 2023-10-05 Illumina Cambridge Limited Methods for chemical cleavage of surface-bound polynucleotides
WO2023186982A1 (en) 2022-03-31 2023-10-05 Illumina, Inc. Compositions and methods for improving sequencing signals
WO2023192900A1 (en) 2022-03-31 2023-10-05 Illumina Singapore Pte. Ltd. Nucleosides and nucleotides with 3' vinyl blocking group useful in sequencing by synthesis
WO2023232829A1 (en) 2022-05-31 2023-12-07 Illumina, Inc Compositions and methods for nucleic acid sequencing
WO2024003087A1 (en) 2022-06-28 2024-01-04 Illumina, Inc. Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing
WO2024039516A1 (en) 2022-08-19 2024-02-22 Illumina, Inc. Third dna base pair site-specific dna detection
WO2024068889A2 (en) 2022-09-30 2024-04-04 Illumina, Inc. Compositions and methods for reducing photo damage during sequencing

Also Published As

Publication number Publication date
CA2398168A1 (en) 2001-08-09
GB0002310D0 (en) 2000-03-22
HK1047771A1 (en) 2003-03-07
AU3038401A (en) 2001-08-14
IL150836A0 (en) 2003-02-12
EP1252332A2 (en) 2002-10-30
JP2003521693A (en) 2003-07-15
IS6489A (en) 2002-07-31
WO2001057248A3 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
EP1252332A2 (en) Polynucleotide arrays and their use in sequencing
US7232656B2 (en) Arrayed biomolecules and their use in sequencing
US20030022207A1 (en) Arrayed polynucleotides and their use in genome analysis
EP1105529B2 (en) Arrayed biomolecules and their use in sequencing
EP1356120A2 (en) Arrayed polynucleotides and their use in genome analysis
EP1597397B1 (en) Dna sequence analysis
US7414115B2 (en) Length determination of nucleic acid repeat sequences by discontinuous primer extension
JP2008500047A (en) Methods and devices for sequencing nucleic acids
WO2006111729A1 (en) Method and device for nucleic acid sequencing using a planar wave guide
US20040175716A1 (en) Dna sequence analysis
WO2011034690A2 (en) Centroid markers for image analysis of high density clusters in complex polynucleotide sequencing
KR20180014054A (en) Orthogonal non-blocking of nucleotides
US7291460B2 (en) Multiplexed systems for nucleic acid sequencing
AU2023244497A1 (en) Paired-end re-synthesis using blocked p5 primers
US20100130368A1 (en) Method and system for sequencing polynucleotides
ZA200100798B (en) Arrayed biomolecules and their use in sequencing.
MXPA01003266A (en) Methods of nucleic acid amplification and sequencing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 150836

Country of ref document: IL

Ref document number: 2001902529

Country of ref document: EP

Ref document number: 30384/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2398168

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2001 555871

Country of ref document: JP

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2001902529

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001902529

Country of ref document: EP